Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Dong Liu, Lara R. Heij, Zoltán Czigány, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Tumour-infiltrating lymphocytes: from prognosis to treatment selection
Koen Brummel, Anneke L. Eerkens, Marco de Bruyn, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 3, pp. 451-458
Open Access | Times Cited: 131
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Mohammad Kazemi, Maryam Sadri, Alireza Najafi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 89
Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application
Yuyuan Zhang, Mengjun Xu, Yuqing Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
Eva Kúdelová, Marek Smolár, Veronika Holubeková, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14937-14937
Open Access | Times Cited: 68
A Noninvasive Approach to Evaluate Tumor Immune Microenvironment and Predict Outcomes in Hepatocellular Carcinoma
Jianmin Wu, Wanmin Liu, Xinyao Qiu, et al.
Phenomics (2023) Vol. 3, Iss. 6, pp. 549-564
Open Access | Times Cited: 31
Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution
Fusheng Zhang, Yongsu Ma, Dongqi Li, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 13
Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma
Sijia Hua, Xinyi Gu, Hangbin Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117080-117080
Open Access | Times Cited: 8
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma
Shin‐Yi Chung, Yi‐Chen Yeh, Chien-Jung Huang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010173-e010173
Open Access | Times Cited: 1
Epigenetic regulation and therapeutic targets in the tumor microenvironment
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 21
Heterogeneity of Cholangiocarcinoma Immune Biology
Francesca Vita, Irene Olaizola, Francesco Amato, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 846-846
Open Access | Times Cited: 18
Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses
Rui He, Yihu Li, Pengcheng Jiao, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1551-1567
Open Access | Times Cited: 6
Predictive and Prognostic Relevance of Tumor-Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types
Tikam Chand Dakal, Nancy George, Caiming Xu, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1626-1626
Open Access | Times Cited: 6
Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
Xianzhe Yu, Lingling Zhu, Ting Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
MUC1 induces the accumulation of Foxp3+ Treg cells in the tumor microenvironment to promote the growth and metastasis of cholangiocarcinoma through the EGFR/PI3K/Akt signaling pathway
Guofeng Zhang, Zheng Ge, Haipeng Zhang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110091-110091
Closed Access | Times Cited: 14
Advances in immunotherapy for biliary tract cancers
Yuhao Zhao, Mao Yang, Jiayi Feng, et al.
Chinese Medical Journal (2023) Vol. 137, Iss. 5, pp. 524-532
Open Access | Times Cited: 14
The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value
Lavinia Patricia Mocan, Ioana Rusu, Carmen Stanca Melincovici, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1542-1542
Open Access | Times Cited: 13
Targeting PD-L1 in Cholangiocarcinoma Using Nanovesicle-Based Immunotherapy
Piyush Gondaliya, Adil Ali Sayyed, Irene K. Yan, et al.
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2762-2777
Open Access | Times Cited: 5
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for immune checkpoint inhibitors in biliary tract cancer
Yeong Hak Bang, Choong‐kun Lee, Kyunghye Bang, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 20, pp. 4635-4643
Closed Access | Times Cited: 5
The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma
Ran Zuo, Fuyi Zhu, Cuicui Zhang, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 16, pp. 1500-1511
Open Access | Times Cited: 12
An overview of extrahepatic cholangiocarcinoma: from here to where?
Yongheng Yang, Xiaolu Zhang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
High immune cell infiltration predicts improved survival in cholangiocarcinoma
Erkki‐Ville Wirta, Säde Szeto, Hanna Koppatz, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 159-179
Open Access | Times Cited: 4
Current development of molecular classifications of gastric cancer based on omics (Review)
Yubo Ma, Zhengchen Jiang, Li-Bin Pan, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Open Access | Times Cited: 4
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
Liye Wang, Pan Li, Shuai Gong, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41600-e41600
Closed Access
Page 1 - Next Page

Scroll to top